Almac Discovery is an independent member of the Almac Group, focused on the discovery and development of novel and innovative approaches to the treatment of cancer and associated conditions.

Since its launch in 2008 Almac Discovery has built a portfolio of therapeutic projects that promise to make a real difference to lives of cancer patients. Although Almac Discovery is a relatively young company, it has already taken programmes through all stages of early drug discovery and development from target finding to Phase I clinical trials. This is reflected in the current pipeline.

A combination of an experienced management team and state of the art facilities based in the UK make Almac Discovery ideally placed to make a difference in the oncology space and an ideal partner for the discovery and development of new therapeutics.